#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Burkitt's lymphoma Pleomorphic leiomyosarcoma Sarcoma Lennox-Gastaut syndrome Pouchitis Systemic lupus erythematosus Raynaud's phenomenon Hidradenitis Necrotising enterocolitis neonatal Mastocytosis Myelofibrosis Haemophilia A with anti factor VIII Haemophilia A without inhibitors Netherton's syndrome Neuroblastoma recurrent More trials…

    Learn about Rare Diseases

    Mastocytosis Fabry’s disease – Diagnostics Choroid melanoma – Basic Information Angiosarcoma metastatic – Diagnostics Hereditary ataxia – Life with Disease Noonan syndrome – Diagnostics Gaucher’s disease type III – Trials in Disease VEXAS syndrome – Basic Information Ocular melanoma Angiosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Risdiplam BUDOPRUTUG Flupentixol Decanoate Alks 2680 Chlorphenamine ZIRCONIUM (89ZR) GIRENTUXIMAB Sonidegib Valbenazine Ditosylate Cerebrolysin Concentrate Vrdn-001 Abacavir Sulfate Ads-011 Mometasone LY4170156 Kd050 Atropine Sulfate PETHIDINE HYDROCHLORIDE Dog Epithelium Extract Quinapril Hydrochloride Osimertinib More therapies…

    Learn about Your Condition

    Colitis Large cell lung cancer Mitochondrial myopathy Partial seizures Pyrexia Meningorrhagia Gastric cancer Myelodysplastic syndrome Osteoarthritis B-cell type acute leukaemia Narcolepsy Red blood cell abnormality Endocarditis enterococcal Round cell liposarcoma Acute lymphocytic leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Tislelizumab and Chemotherapy for Patients with Stage III PD-L1 Positive Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Tislelizumab
    • Carboplatin
    • Cisplatin
    Italy

  • Study on Reducing Ischemic Stroke Damage with Low-Dose Human Albumin Solution and Sodium Chloride in Adult Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Human Albumin Solution
    • Sodium Chloride
    Czechia

  • Study on the Effects of Vaginal Estrogen Treatment with Nomegestrol Acetate and Estradiol Hemihydrate on Blood Clotting in Postmenopausal Women with Vaginal Atrophy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrophic vulvovaginitis
    • Stress urinary incontinence
    • Urinary incontinence
    Investigated Drugs:
    • Estradiol Hemihydrate
    • Nomegestrol Acetate
    Denmark

  • Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Pirtobrutinib
    • Obinutuzumab
    • Venetoclax
    Austria Belgium Czechia Denmark Finland France +8

  • Study of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Amlodipine
    • Amlodipine Besilate
    • Eplerenone
    Poland

  • Study of Pembrolizumab for Patients with High-Risk Thyroid Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Thyroid cancer
    Investigated Drugs:
    • Pembrolizumab
    Italy
Previous Page
1 … 239 240 241 242 243 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!